510(k) Report

510(k) · Cleared

Cleared

Bard Pelvisoft Acellular Collagen Biomesh

K031332510(k) AbbreviatedCleared May 15, 200317-day reviewClass II21 CFR 878.3300

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

C.R. Bard, Inc. · FTM Mesh, Surgical

Cleared on May 15, 2003 after a 17-day review. The FDA summary names its predicate without a number. 15 later devices descend from it.

Decided
May 15, 2003
Review
17 days
Class
Class II
Product code
FTM
Recalls
None
Predicates
0

15 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2008: 1 descendant cleared2014: 1 descendant cleared2011: 2 descendants cleared2016: 1 descendant cleared2017: 1 descendant cleared2022: 1 descendant cleared2023: 1 descendant cleared2025: 3 descendants cleared2026: 3 descendants cleared2024: 1 descendant cleared200020052010201520202025
  1. This deviceK031332 Bard Pelvisoft Acellular Collagen BiomeshC.R. Bard, Inc. · 2003
  2. Descendant · cites it directly · 14 of its ownK082176 LTM-BPS Surgical MeshLifecell Corp. · 2008
  3. Descendant · 2 generations on · 11 of its ownK142326 HP Tissue MatrixLifecell Corporation · 2014
  4. Descendant · 2 generations on · 9 of its ownK151083 BioBridge Collagen MatrixFibralign Corporation · 2016
  5. Descendant · 3 generations on · 4 of its ownK222978 Poly-Tape/Infinity-Lock Soft Tissue Reinforcement DeviceXiros, Ltd. · 2022
  6. Descendant · 3 generations on · 3 of its ownK230316 FlexBand; FlexPatch; FlexBand PlusInternational Life Sciences · 2023 · Recalled

Showing 5 of 15 descendants. See all descendants

Descendants cleared per year

2008: 12011: 22014: 12016: 12017: 12022: 12023: 12024: 12025: 32026: 3
2008high 3 (2025) · low 0 (2009)2026

Most influential descendants

Showing 5 of 15 · See all
  • K082176LTM-BPS Surgical MeshLifecell Corp. · 2008 · cites it directly14descendants
  • K142326HP Tissue MatrixLifecell Corporation · 2014 · 2 generations on11descendants
  • K151083BioBridge Collagen MatrixFibralign Corporation · 2016 · 2 generations on9descendants
  • K222978Poly-Tape/Infinity-Lock Soft Tissue Reinforcement DeviceXiros, Ltd. · 2022 · 3 generations on4descendants
  • K230316FlexBand; FlexPatch; FlexBand PlusInternational Life Sciences · 2023 · 3 generations on3descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K031332Bard Pelvisoft Acellular Collagen BiomeshC.R. Bard, Inc.2003—
+1K082176LTM-BPS Surgical MeshLifecell Corp.2008—
+2K142326HP Tissue MatrixLifecell Corporation2014—
+2K151083BioBridge Collagen MatrixFibralign Corporation2016—
+3K222978Poly-Tape/Infinity-Lock Soft Tissue Reinforcement DeviceXiros, Ltd.2022—
+3K230316FlexBand; FlexPatch; FlexBand PlusInternational Life Sciences20233

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200810
201120
201410
201610
201710
202210
202310
202410
202530
202630
FIG. 1 — Lineage of K031332, 2003–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FTM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FTM device

  1. #1 K262406 EluPro Antibiotic-Eluting BioEnvelopescore 15.1 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Permacol® Acellular Collagen Matrix
Named without a submission number
—
*—SurgiSIS™
Named without a submission number
—

What descends from it? (15)

See all 15

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K082176LTM-BPS Surgical MeshLifecell Corp.200814

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K082176 (Lifecell Corp., 2008) has gone furthest, with 14 descendants of its own.

How does its category compare?

All FTM devices

FTM Mesh, Surgical: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FTM

1in 2025

2007: 92008: 92009: 72010: 22011: 62012: 42013: 42014: 82015: 42016: 72017: 92018: 22019: 62020: 42021: 42023: 22024: 32025: 12026 (partial year): 1
2007high 9 (2007) · low 0 (2022)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FTM

29in 2024

2007: 104 days median2008: 86 days median2009: 86 days median2011: 100 days median2012: 66 days median2013: 123 days median2014: 153 days median2015: 316 days median2016: 88 days median2017: 147 days median2019: 107 days median2020: 59 days median2021: 61 days median2024: 29 days median
2007high 316 (2015) · low 29 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FTM

1in 2023

2007: 72008: 12010: 12011: 82018: 212019: 42020: 12021: 12023: 1
2007high 21 (2018) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FTM

232in 2025

2007: 602008: 1412009: 4762010: 1972011: 2882012: 4672013: 3,3512014: 1,0932015: 9772016: 5092017: 5292018: 3572019: 4182020: 4572021: 3692022: 3752023: 4852024: 3832025: 232
2007high 3,351 (2013) · low 60 (2007)2025

MAUDE reports naming product code FTM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20079104760
20089861141
20097860476
20102—1197
201161008288
20124660467
2013412303,351
2014815301,093
201543160977
20167880509
201791470529
20182—21357
201961074418
20204591457
20214611369
20220—0375
20232—1485
20243290383
20251—0232
20261—0—

What is it indicated for?

Bard® PelviSoft™ Acellular Collagen BioMesh is intended for use as a soft tissue patch to reinforce soft tissue where weakness exists and for the surgical repair of damaged or ruptured soft tissue membranes. It is specifically indicated for urethral procedures, vaginal prolapse, and reconstruction of the pelvic floor.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K031332: Bard Pelvisoft Acellular Collagen Biomesh.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K031332

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026